|
1
|
Eltzschig HK and Eckle T: Ischemia and
reperfusion-from mechanism to translation. Nat Med. 17:1391–1401.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maes C, Carmeliet G and Schipani E:
Hypoxia-driven pathways in bone development, regeneration and
disease. Nat Rev Rheumatol. 8:358–366. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van de Sluis B, Groot AJ, Vermeulen J, van
der Wall E, van Diest PJ, Wijmenga C, Klomp LW and Vooijs M: COMMD1
Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via
HSP90/70. PLoS One. 4:e73322009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yao HC, Liu T, Meng XY, Han QF, Zhang M
and Wang LX: Effect of basic fibroblast growth factor on the
myocardial expression of hypoxia-inducible factor-1α and vascular
endothelial growth factor following acute myocardial infarctio.
Heart Lung Circ. 22:946–951. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li J, Kokkola R, Tabibzadeh S, Yang R,
Ochani M, Qiang X, Harris HE, Czura CJ, Wang H, Ulloa L, et al:
Structural basis for the proinflammatory cytokine activity of high
mobility group box 1. Mol Med. 9:37–45. 2003.PubMed/NCBI
|
|
6
|
Yan XX, Lu L, Peng WH, Wang LJ, Zhang Q,
Zhang RY, Chen QJ and Shen WF: Increased serum HMGB1 level is
associated with coronary artery disease in nondiabetic and type 2
diabetic patients. Atherosclerosis. 205:544–548. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kohno T, Anzai T, Naito K, Miyasho T,
Okamoto M, Yokota H, Yamada S, Maekawa Y, Takahashi T, Yoshikawa T,
et al: Role of high-mobility group box 1 protein in post-infarction
healing process and left ventricular remodelling. Cardiovasc Res.
81:565–573. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Avalos AM, Kiefer K, Tian J, Christensen
S, Shlomchik M, Coyle AJ and Marshak-Rothstein A: RAGE-independent
autoreactive B cell activation in response to chromatin and
HMGB1/DNA immune complexes. Autoimmunity. 43:103–110. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ding HS and Yang J: High mobility group
box-1 and cardiovascular diseases. Saudi Med J. 31:486–489.
2010.PubMed/NCBI
|
|
10
|
Yao HC, Zhao AP, Han QF, Wu L, Yao DK and
Wang LX: Correlation between serum high-mobility group box-1 levels
and high-sensitivity C-reactive protein and troponin I in patients
with coronary artery disease. Exp Ther Med. 6:121–124.
2013.PubMed/NCBI
|
|
11
|
Ulloa L and Messmer D: High-mobility group
box 1 (HMGB1) protein: Friend and foe. Cytokine Growth Factor Rev.
17:189–201. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu H, Yao Y, Su Z, Yang Y, Kao R, Martin
CM and Rui T: Endogenous HMGB1 contributes to
ischemia-reperfusion-induced myocardial apoptosis by potentiating
the effect of TNF-α/JNK. Am J Physiol Heart Circ Physiol.
300:H913–H921. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ran K, Gong ZX, Yang DL, Chang YT, Duan KM
and Ou YW: Effect of morphine preconditioning in the delayed phase
on the expression of p38 mitogen-activated protein kinase in a
rabbit model of myocardial ischemia-reperfusion injury. Genet Mol
Res. 14:6642–6648. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Limana F, Germani A, Zacheo A, Kajstura J,
Di Carlo A, Borsellino G, Leoni O, Palumbo R, Battistini L,
Rastaldo R, et al: Exogenous high-mobility group box 1 protein
induces myocardial regeneration after infarction via enhanced
cardiac C-kit+ cell proliferation and differentiation. Circ Res.
97:e73–e83. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Limana F, Esposito G, Fasanaro P, Foglio
E, Arcelli D, Voellenkle C, Di Carlo A, Avitabile D, Martelli F,
Russo M Antonio, et al: Transcriptional profiling of hmgb1-induced
myocardial repair identifies a key role for notch signaling. Mol
Ther. 21:1841–1851. 2013. View Article : Google Scholar
|
|
16
|
Abarbanell AM, Hartley JA, Herrmann JL,
Weil BR, Wang Y, Manukyan MC, Poynter JA and Meldrum DR: Exogenous
high-mobility group box 1 improves myocardial recovery after acute
global ischemia/reperfusion injury. Surgery. 149:329–335. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang DY, Zhang AX, Zhou YH, Wang LH and
Yao HC: Protection of intravenous HMGB1 on myocardial ischemia
reperfusion injury. Int J Cardiol. 184:280–282. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Biscetti F, Ghirlanda G and Flex A:
Therapeutic potential of high mobility group box-1 in ischemic
injury and tissue regeneration. Curr Vasc Pharmacol. 9:677–681.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
National Research Council, . Guide for the
Care and Use of Laboratory Animals. 8th. The National Academies
Press; Washington, DC: 2011, PubMed/NCBI
|
|
20
|
Takahashi K, Fukushima S, Yamahara K,
Yashiro K, Shintani Y, Coppen SR, Salem HK, Brouilette SW, Yacoub
MH and Suzuki K: Modulated inflammation by injection of
high-mobility group box 1 recovers post-infarction chronically
failing heart. Circulation. 118 14 Suppl:S106–S114. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Limana F, Esposito G, D'Arcangelo D, Di
Carlo A, Romani S, Melillo G, Mangoni A, Bertolami C, Pompilio G,
Germani A and Capogrossi MC: HMGB1 attenuates cardiac remodelling
in the failing heart via enhanced cardiac regeneration and
miR-206-mediated inhibition of TIMP-3. PLoS One. 6:e198452011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yao HC, Yang LJ, Han QF, Wang LH, Wu L,
Zhang CY, Tian KL and Zhang M: Postconditioning with simvastatin
decreases myocardial injury in rats following acute myocardial
ischemia. Exp Ther Med. 9:1166–1170. 2015.PubMed/NCBI
|
|
23
|
Chen M, Huang W, Wang C, Nie H, Li G, Sun
T, Yang F, Zhang Y, Shu K, Wang C and Gong Q: High-mobility group
box 1 exacerbates CCl4-induced acute liver injury in mice. Clin
Immunol. 153:56–63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou X, Hu X, Xie J, Xu C, Xu W and Jiang
H: Exogenous high-mobility group box 1 protein injection improves
cardiac function after myocardial infarction: Involvement of Wnt
signaling activation. J Biomed Biotechnol. 2012:7438792012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He Y, Zhou X, Zheng X and Jiang X:
Exogenous high-mobility group box 1 protein prevents postinfarction
adverse myocardial remodeling through TGF-β/Smad signaling pathway.
J Cell Biochem. 114:1634–1641. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Khimenko PL, Bagby GJ, Fuseler J and
Taylor AE: Tumor necrosis factor-alpha in ischemia and reperfusion
injury in rat lungs. J Appl Physiol (1985). 85:2005–2011.
1998.PubMed/NCBI
|
|
27
|
Zhu J, Liu M, Kennedy RH and Liu SJ:
TNF-alpha-induced impairment of mitochondrial integrity and
apoptosis mediated by caspase-8 in adult ventricular myocytes.
Cytokine. 34:96–105. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jahangiri A, Leifert WR, Kind KL and
McMurchie EJ: Dietary fish oil alters cardiomyocyte Ca2+ dynamics
and antioxidant status. Free Radic Bio Med. 40:1592–1602. 2006.
View Article : Google Scholar
|
|
29
|
Matsui Y, Takagi H, Qu X, Abdellatif M,
Sakoda H, Asano T, Levine B and Sadoshima J: Distinct roles of
autophagy in the heart during ischemia and reperfusion: Roles of
AMP-activated protein kinase and Beclin 1 in mediating autophagy.
Circ Res. 100:914–922. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rapino C, Bianchi G, Di Giulio C,
Centurione L, Cacchio M, Antonucci A and Cataldi A: HIF-1alpha
cytoplasmic accumulation is associated with cell death in old rat
cerebral cortex exposed to intermittent hypoxia. Aging Cell.
4:177–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
AI-Salam S and Hashmi S: Galectin-1 in
early acute myocardial infarction. PLoS One. 9:e869942014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cai Z, Luo W, Zhan H and Semenza GL:
Hypoxia-inducible factor 1 is required for remote ischemic
preconditioning of the heart. Proc Natl Acad Sci USA. 110:pp.
17462–17467. 2013; View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li Q Fang, Xu H, Sun Y, Hu R and Jiang H:
Induction of inducible nitric oxide synthase by isoflurane
post-conditioning via hypoxia inducible factor-1α during tolerance
against ischemic neuronal injury. Brain Res. 1451:1–9. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li X, Zhao H, Wu Y, Zhang S, Zhao X, Zhang
Y, Wang J, Wang J and Liu H: Up-regulation of hypoxia-inducible
factor-1α enhanced the cardioprotective effects of ischemic
postconditioning in hyperlipidemic rats. Acta Biochim Biophys Sin
(Shanghai). 46:112–118. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Poynter JA, Manukyan MC, Wang Y, Brewster
BD, Herrmann JL, Weil BR, Abarbanell AM and Meldrum DR: Systemic
pretreatment with dimethyloxalylglycine increases myocardial HIF-1α
and VEGF production and improves functional recovery after acute
ischemia/reperfusion. Surgery. 150:278–283. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cai Z, Zhong H, Bosch-Marce M, Fox-Talbot
K, Wang L, Wei C, Trush MA and Semenza GL: Complete loss of
ischaemic preconditioning-induced cardioprotection in mice with
partial deficiency of HIF-1 alpha. Cardiovasc Res. 77:463–470.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Adluri RS, Thirunavukkarasu M, Dunna NR,
Zhan L, Oriowo B, Takeda K, Sanchez JA, Otani H, Maulik G, Fong GH
and Maulik N: Disruption of hypoxia-inducible transcription
factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo
myocardial ischemia/reperfusion injury through hypoxia-inducible
factor-1α transcription factor and its target genes in mice.
Antioxid Redox Signal. 15:1789–1797. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ke Q and Costa M: Hypoxia-inducible
factor-1 (HIF-1). Mol Pharmacol. 70:1469–1480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Si J, Wang N, Wang H, Xie J, Yang J, Yi H,
Shi Z, Ma J, Wang W, Yang L, et al: HIF-1α signaling activation by
post-ischemia treatment with astragaloside IV attenuates myocardial
ischemia-reperfusion injury. PLoS One. 9:e1078322014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Oriowo B, Thirunavukkarasu M, Selvaraju V,
Adluri RS, Zhan L, Takeda K, Fong GH, Sanchez JA and Maulik N:
Targeted gene deletion of prolyl hydroxylase domain protein 3
triggers angiogenesis and preserves cardiac function by stabilizing
hypoxia inducible factor 1 alpha following myocardial infarction.
Curr Pharm Des. 20:1305–1310. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ong SG, Lee WH, Theodorou L, Kodo K, Lim
SY, Shukla DH, Briston T, Kiriakidis S, Ashcroft M, Davidson SM, et
al: HIF-1 reduces ischaemia-reperfusion injury in the heart by
targeting the mitochondrial permeability transition pore.
Cardiovasc Res. 104:24–36. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yuan X, Niu HT, Wang PL, Lu J, Zhao H, Liu
SH, Zheng QS and Li CG: Cardioprotective effect of licochalcone d
against myocardial ischemia/reperfusion injury in
langendorff-perfused rat hearts. PLoS One. 10:e01283752015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kumphune S, Surinkaew S, Chattipakorn SC
and Chattipakorn N: Inhibition of p38 MAPK activation protects
cardiac mitochondria from ischemia/reperfusion injury. Pharm Biol.
53:1831–1841. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang X, Lv H, Gu Y, Wang X, Cao H, Tang Y,
Chen H and Huang C: Protective effect of lycopene on cardiac
function and myocardial fibrosis after acute myocardial infarction
in rats via the modulation of p38 and MMP-9. J Mol Histol.
45:113–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
